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1. Introduction 
Heparin acts as an anticoagulant by binding to anti- 
thrombin III and by accelerating the rate at which this 
protein inactivates thrombin and other serine pro- 
teases of the intrinsic clotting system [ 11. Purified 
commercial preparations of heparin contain two spe- 
cies of the molecules that can be separated on the 
basis of their affinity to antithrombin III [2-41. The 
high affinity heparin (HA-heparin) binds to anti- 
thrombin III in a 1 :l stoichometry withK,8 X lo7 M 
[5]. Low-affinity heparin (LA-heparin) presumably 
binds to the same site of antithrombin III with an 
association constant 100-1000 times lower than that 
determined for the antithrombin III-HA-heparin 
binding [6]. The anticoagulant activity of LA-hepa- 
rin is lo-100 times lower than that of HA-heparin, 
the ratio varying with the assay system used [7]. There 
is a good evidence that lysine may function as a 
heparin-binding site on antithrombin III molecule [ I]. 
It was suggested [8] that a specific tetrasaccharide 
with a N-sulfated glucosamine at its reducing end and 
equivalent amounts of glucuronic and iduronic acid is 
a specific structural requirement for the interaction 
of heparin with antithrombin III. More recent data 
indicate that non-sulfated L-iduronic acid represents 
a structural feature that is essential for the antico- 
agulant activity of heparin (U.L., Backstrom, Hook, 
Thunberg, Fransson and Linker, unpublished data). 
Stimulated platelets secrete two heparin binding 
proteins: platelet factor 4 (PF,) and low affinity 
platelet factor 4 (LA-PF4) [9]. Platelet factor 4 is 
one of the most potent agents neutralizing the anti- 
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coagulant activity of heparin. It is a single chain low 
molecular weight (7800) polypeptide [lo-l 21, with 
a high affinity for heparin and a lower affinity to 
such glycosaminoglycans as heparan sulfate and 
dermatan sulfate [ 131. The lysine residues clustered 
at the C-terminus of PF4 are apparently involved in 
the interaction with heparin [ 141. Evidence has been 
presented that PF4 does not interfere with thrombin 
neutralization by antithrombin III [ 1.51. 
The purpose of this study was to compare binding 
of platelet antiheparin proteins and of antithrombin 
III to LA- and HA-heparin. Both species of heparin 
as well as unfractionated pig mucosal heparin were 
attached to CNBr-Sepharose. Then adsorbtion of 
three proteins (antithrombin III, LA-PF4 and PF,) 
and their patterns of elution from columns containing 
the insolubilized heparins were compared. Our data 
indicate that antithrombin III and platelet antiheparin 
proteins bind to different sites on heparin molecule. 
2. Materials and methods 
Unfractionated heparin obtained from pig intestinal 
mucosa was supplied by Sigma Co, (St Louis, MO). 
This heparin contained 1.50 USP units/mg. Low affinity 
and high affinity heparins were obtained from pig 
mucosal heparin by affinity chromatography on anti- 
thrombin III-Sepharose as in [2]. The anticoagulant 
activities of HA-heparin and LA-heparin were 19 and 
285 units/mg, respectively. The HA- and LA-heparin 
preparations were both polydisperse and overlapped on 
Sephadex G-100 gel chromatography [16]. The peak 
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K,, values were 0 16 and 0 26, respectively, corre- 
sponding to mol wt -19 000-20 000 and 14 OOO- 
15 000 All three species of heparm were coupled to 
CNBr-Sepharose (Pharmaaa, Uppsala) m the propor- 
tion of 10 mg heparm/ 1 g CNBr-Sepharose [ 171 
Washed platelets were prepared as m [ 181 and 
suspended m Tyrode-albumin solution Ionophore 
A 23187 wasadded to platelet suspenslon,O 65pg/109 
cells After 3 mm mcubatlon at 37°C platelet aggre- 
gates were centrifuged at 2000 X g for 10 mm The 
supernatant obtained from 4 X lo9 platelets/l ml 
contained about 1 3 mg total protem, 100 pg LA-PF4 
and 40 pg PF, per ml 
PF4 and LA-PF, were prepared as m [9] Both prep- 
arations were homogenous as tested m SDS-poly- 
acrylamlde gel electrophoresls 
Antlthrombm III purified by the method m [ 191 
was a gift of Dr R Rosenberg (Harvard Umverslty, 
Boston, MA) 
Radlolodmatlon of LA-PF4, PF4 and antlthrombm 
III was done with Na12’1 and chloramme T using a 
modlficatlon of the method of Hunter [9,20] The 
specific radloactlvltles of LA-PF4, antlthrombm III 
and PF, were 30 ,uCl/pg protem, 30 @Zl/pg protein 
and 10 pCl/mg protem, respectively Before apphca- 
tlon on the columns all three labeled tracers were 
diluted by unlabeled protems m the proportion of 
1 4000 
Protein was determined by the Lowry method [71] 
3 Results and discussion 
In the first series of experiments three radlolabeled 
proteins ([ 1251]antlthron~bm III, [ “‘I]PF4 and LA-[1251]- 
PF,) were applied on three types of hepann-Sepharose 
columns and their elutlon patterns were followed by 
measuring the “‘1 radloactlvlty In the second series 
of expenments supernate from platelets aggregated 
by lonophore was apphed on the same columns and 
the elutlon patterns of PF4 and LA-PF, were followed 
by rddioimmunoassay The results of these experiments 
are presented m the table 1 It can be seen that under 
these experimental condltlons [‘2SI]antlthrombm III 
was retained on unfractlonated heparu-Sepharose 
and on HA-heparu-Sepharose, but It was not retamed 
on LA-heparu-Sepharose Elutlon of [‘2SI]antl- 
thrombm III occurred at 0 2-O 75 M NaCl, with a 
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‘peak’ at 0 45-O 65 M LA-[ 12’I]PF4 and [ 1251]PF4 
were adsorbed on msolublhzed unfractlonated hepa- 
rm. LA-heparm, and HA-heparm. respectively. and it 
was found that the elutlon pattern of either protem 
from these columns was independent of the type of 
heparm Similar results were obtamed by applying the 
platelet supernate on the columns contammg all three 
types of msolubdlzed heparm It should be pomted 
out, however, that LA-PF4 m platelet supernate was 
completely retamed m all three columns while m exper- 
iments with LA-[ ‘*‘I]PF, -3O:h of the radioactive 
material was not retained on heparn-agarose equl- 
hbrated with 0 15 M NaCl An excess of anti-LA-PF4 
antibody precipitated only 44% of this material which 
probably corresponded to partially denatured protein 
95% material eluted with 0 4 M NaCl was preclpltatid 
m the same condltlon The major portion of either 
LA-[ 1251]PF4 or unlabeled LA-PF4 was eluted at 
0 4 M NaCl from all types of msolublhzed heparms 
PF, showed much higher affinity to heparms, but 
again no differences between elutlon from LA-heparm 
and HA-heparm were observed It can be seen, how- 
ever, that purification and lodmatlon shghtly decreased 
binding affinity ofPF, to all three msolubllized hepa- 
rms Figures 1 and 2 show representative xperiments 
m which supernates from aggregated platelets were 
applied on LA-heparm -agarose and HA-heparu- 
agarose Both LA-PF4 and PF4 showed a distinct elu- 
tlon pattern, however, the type of heparm coupled to 
sephdrose did not influence the binding affinity of 
any of the proteins 
The above experiments demonstrated that LA-he- 
parm and HA-heparm show equal ability to Interact 
with the platelet antlheparm proteins LA-PF4 and 
PF4 Since the two types of heparm are dlfferentlated 
solely on the basis of affinity for antlthrombm III these 
results indicate thdt the specific structure required for 
mteractlon with antlthrombm III differs from that 
required for interaction with platelet antlheparm pro- 
teins It appears that PF4 and antlthrombm III bmd 
to different sites on the heparm molecule More 
recently Hdndm, Jordan and Rosenberg (personal 
commumcatlon) reached similar conclusion by mea- 
suring mtrmslc fluorescence of antlthrombm III mter- 
acting with heparm and PF4 
Our data are m agreement with the reports that 
LA-PF4 [9] and flG [ 311 show low affinity bmdmg 
to hepann LA-PF4 appears to be a precursor of 
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Table 1 
Elution of antithrombin III, LA-PF, and PF, from heparin-Sepharose columnsa 
.._ _..- -__ 
Ligand Molar concentrations of NaCl required for ligand elutionb 
___..-_ _... “..^___ 
Unfractionated 
heparin-Seph~ose 
LA-heparin- 
Sepharose 
[ ‘Z*l]Antithrombin 111 0.45 
(0.2-0.75) 
LA-[ r2SI]Pf-4C 0.35 
(0.2-0.4) 
[ ‘=I]PF4 1.2 
LA-PFad 
(0.95-1.25) 
0.4 
PF,d 
(0.25 -0.6) 
1.35 
(1.25-1.40) 
0.15 
0.35 0.4 
(0.25 -0.5) (0.25-0.45) 
1.05 1.15 
(0.8-1.2) (0.85-1.25) 
0.4 0.35 
(0.2-0.55) (0.25-0.6) 
1.4 1.4 
(1.25-1.5) (1.2-1.45) 
HA-heparin- 
Sepharose 
._~ 
0.65 
June 1979 
___~ - 
a Samples were applied to 3 ml heparin-agarose columns. All columns were equi- 
librated with 0.15 M NaCl-0.05 M Tris (pH 8.0) except for columns on which 
(‘2SI]PF, was applied. Those columns were equilibrated with 0.4 M NaCl-0.05 M 
Tris (pH 5.0). The material not retained on the columns was washed out with 
this buffer. Then elution of bound proteins was achieved by applying a continuous 
gradient of NaCl. Each collected sample was 1.4 ml. The concentration of NaCl 
was determined by measurement of conductivity. In experiments with radiola~led 
proteins, the ‘*‘I radioactivity of each sample was measured in an Intertechnique 
gamma counter. In all other experiments the levels of PF, and LA-PF, were 
determined by specific radioimmunoassay [ 9 ] 
b The values in brackets refer to the ranges of NaCl concentrations at which the 
specific activity was eluted. The singlevalues indicate NaCl concentration at which 
‘peak’ activity was eluted 
c In all experiments with LA-[‘ZSI]PF4, -30% of the radioactive material failed to 
bind to heparin-Sepharose quilibrated with 0.15 M NaCl 
d Supernate released from washed platelets aggregated by ionophore A23 187 was 
used as a source of LA-PF, and PF, 
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Fig.1. Elution of LA-PF, and PF, from LA-heparin-Sep- 
harose. The volume of the sample (supernate after platelet 
aggregation) applied on the column was 12.0 ml. 
LA-PF, 
P(lJml 
MOLARITY 
OF NoCl 
**a. 
2.0 
I .0 
I .6 
I .4 
I .2 
I .o 
0.8 
0.6 
04 
0.2 
0 IO 20 30 40 50 60 70 
TUBE NUMBER 
Fig.2 Elution of LA-PF, and PF, from LA-heparin-Sep- 
harose. The volume of the sample (supernate after platelet 
aggregation) applied on the column was 12.0 ml. 
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/3-thromboglobulm (/?TG). another platelet secretory 
protein PTG shows deletion of 4 ammo acids (Asn- 
Leu-Ala-Lys) at the N-terminal end of LA-PF4 The 
remammg ammo acid sequences of LA-PF, and flG 
appear to be Identical [9] The complete ammo acid 
sequence of /3TG (mol wt 8800) shows -50% homol- 
ogy with the sequence of PF4 [23] Since both pro- 
tems show typical clusters of lysme at then C-terminal 
ends, it can be suggested that lysme IS also involved 
m the mteractlon of LA-PF4 or /3TG with heparm 
Prehmmary experiments performed m our laboratories 
mdlcate that LA-PF4 also binds to heparan sulfate at 
physlologlcal ionic strength 
It was demonstrated [24] that HA- and LA-heparm 
have equal ability to Interact with hpoprotem hpase 
and that the speclflc heparm structure required for 
mteraLtlon with antlthrombm III differs from that 
required for mteractlon with hpoprotem hpase The 
relatlonshlp between hpoprotem hpase and PF, bmd- 
mg sites on the heparm molecule remains to be deter- 
mmed 
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